Decreasing trends in HTLV-1/2 but stable HIV-1 infection among replacement donors in Argentina

Journal of Medical Virology

Volumn 82, Issue 5, 2010, Pages 873-877

  Berini, Carolina A ^a   Gendler, Silvina A ^b   Pascuccio, Susana ^b   Eirin, Maria E ^a   McFarland, Willi ^c   Page, Kimberly ^c   Carnevali, Luisa ^b   Murphy, Edward ^d,e   Biglione, Mirna M ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HOSPITAL JUAN A FERNÁNDEZ   (Argentina)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BLOOD SYSTEMS RESEARCH INSTITUTE   (United States)

Author keywords

Argentina; Blood donors; HIV; HTLV

Indexed keywords

ADULT; ARGENTINA; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; COMORBIDITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; RETROSPECTIVE STUDY; SEROLOGY; VIRUS INFECTION;

ADULT; ANIMALS; ARGENTINA; BLOOD DONORS; COMORBIDITY; FEMALE; HIV INFECTIONS; HTLV-I INFECTIONS; HTLV-II INFECTIONS; HUMANS; MALE; PREVALENCE; YOUNG ADULT;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2;

EID: 77950988539     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21728     Document Type: Article

References (13)

1. Berini C, Pascuccio S, Bautista C, Gendler S, Eirin ME, Rodriguez C, Pando MA, Salomon H, Biglione MM. 2008. Comparison of four commercial screening assays for the diagnosis of human T-cell lymphotropic virus types 1 and 2. J Virol Methods 147:322-327.
2. Biglione MM, Astarloa L, Salomon HE. 2005. High prevalence of HTLV-I and HTLV-II among blood donors in Argentina: A South American Health Concern. AIDS Res Hum Retroviruses 21:1-4.
3. Del Pino N, Martínez Peralta L, Pampuro S, Pimentel E, Libonatti O. 1994. HTLV-I/II seroprevalence and coinfection with other pathogens in Blood Donors in Buenos Aires. J Acquir Immune Defic Syndr 7:206-207.
4. Informe del Control de Sangre a Transfundir. 2007. Available at www.anlis.gov.ar [accessed December 30, 2008].
5. Lombardi V, Carrillo MG, Alimandi M, Boxaca M, Rossi P, Libonatti O. 1991. Overt and latent HIV 1 and HTLV-I infection in cohorts of at high risk individuals in Argentina. Mol Cell Probes 5:409-417.
6. Ministerio de Salud y Ambiente. 2009. Seguridad Transfusional. Available at www.msal.gov.ar/htm/plan-nacional-donacion-sangre/documentos/seguridad- transfusional.doc [accessed January 7, 2009].
7. Ministerio de Salud y Ambiente de la Nación. 2008. Boletín sobre VIH/ SIDA en la Argentina. Año XI, Número 25, Agosto 2008, p 7.
8. Pampuro SE, Rabinovich RD, Martinez Peralta L, Gallo D, Hanson C, Libonatti O. 1993. Presence of human T-cell lymphotropic virus types I and II and coinfection with human immunodeficiency virus in different groups at risk in Argentina. J Acquir Immune Defic Syndr 6:851-852.
9. Pan American Health Organization. 1998. Blood bank situation in Latin America, 1996: Serological markers for communicable diseases in blood donors. Epidemiol Bull 19:12-14.
10. Perez Bianco R, Santarelli MT. 1993. Analysis of a national survey for diseases transmitted by blood transfusion. Medicina (B Aires) 53:491-496.
11. Saguier MC, Góngora GN, Houriet S, Reybaud JF, Blejer JL, Galli AC, Salamone HJ. 2003. Seroprevalencia en donantes voluntarios de sangre. Rev Arg Transfus 29:38.
12. Salud Pública Resolución 58/2005. 2005. B.O. 31/01/05-MSA-Normas Técnicas y Administrativas de la Especialidad Hemoterapia. Available at www.femeba.org.ar [accessed March 22, 2009].
13. Schmunis GA, Zicker F, Segura EL, del Pozo AE. 2000. Transfusion- transmitted infectious diseases in Argentina, 1995 through 1997. Transfusion 40:1048-1053.